Astellas Pharma EMEA est présente dans 40 pays à travers l’Europe, le Moyen-Orient et l’Afrique. Le siège monde Astellas Pharma Inc. est basé à Tokyo.
Europe is a global centre of excellence in healthcare and Astellas is committed to supporting Europe, the Middle East and Africa (EMEA), by working in partnership with local governments to ensure patients can benefit from our medicines.
According to the World Health Organisation (WHO), Europe boasts some of the best healthcare systems on the planet.(1) But there are wide variations in the local needs of different countries in the EMEA region. The EMEA headquarters of Astellas brings the specialist knowledge required to ensure our research programmes and medicines meet the requirements of individual markets in which doctors and patients live – as well as the medical and regulatory organisations that support them.
1. World Health Organization. The World Health Report 2000. Health Systems: Improving Performance. Available at www.who.int/whr/2000/en/whr00_en.pdf. Last accessed 25 February 2013.